Suppr超能文献

肠易激综合征的疼痛:有什么真正有效的方法吗?

Pain in irritable bowel syndrome: Does anything really help?

机构信息

Division of Gastroenterology and Hepatology, Clinical Enteric Neuroscience Translational and Epidemiological Research (CENTER), Mayo Clinic, Rochester, Minnesota, USA.

出版信息

Neurogastroenterol Motil. 2022 Jan;34(1):e14305. doi: 10.1111/nmo.14305. Epub 2021 Dec 3.

Abstract

Pain relief remains a significant challenge in the management of irritable bowel syndrome (IBS): "Does anything really help relieve the pain in patients with IBS?". Interventions aimed at pain relief in patients with IBS include diet, probiotics or antibiotics, antidepressants, antispasmodics, and drugs targeting specific gastrointestinal receptors such as opioid or histamine receptors. In the systematic review and meta-analysis published in this journal, Lambarth et al. examined the literature on the role of oral and parenteral anti-neuropathic agents in the management of pain in patients with IBS. This review article appraises their assessment of the efficacy of the anti-neuropathic agents amitriptyline, pregabalin, gabapentin, and duloxetine in the relief of abdominal pain or discomfort, and impact on overall IBS severity and quality of life. This commentary provides an update of current evidence on the efficacy of the dietary and pharmacological treatments that are available or in development, as well psychological and cognitive behavioral therapy for pain in IBS. Advances in recent years augur well for efficacious treatments that may expand the therapeutic arsenal for pain in IBS.

摘要

缓解疼痛仍然是肠易激综合征(IBS)管理中的一个重大挑战:“有什么真的可以帮助缓解 IBS 患者的疼痛吗?”。针对 IBS 患者的疼痛缓解干预措施包括饮食、益生菌或抗生素、抗抑郁药、抗痉挛药以及针对特定胃肠道受体的药物,如阿片类或组胺受体。在本期杂志上发表的系统评价和荟萃分析中,Lambarth 等人研究了口服和肠外抗神经病理性药物在 IBS 患者疼痛管理中的作用的文献。这篇综述文章评估了抗神经病理性药物阿米替林、普瑞巴林、加巴喷丁和度洛西汀缓解腹痛或不适的疗效,以及对 IBS 总体严重程度和生活质量的影响。本文对目前可获得或正在开发的饮食和药物治疗以及针对 IBS 疼痛的心理和认知行为疗法的疗效提供了最新信息。近年来的进展预示着有效的治疗方法可能会扩大 IBS 疼痛的治疗武器库。

相似文献

1
Pain in irritable bowel syndrome: Does anything really help?
Neurogastroenterol Motil. 2022 Jan;34(1):e14305. doi: 10.1111/nmo.14305. Epub 2021 Dec 3.
3
Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome.
Cochrane Database Syst Rev. 2011 Aug 10;2011(8):CD003460. doi: 10.1002/14651858.CD003460.pub3.
4
Dietary and pharmacological treatment of abdominal pain in IBS.
Gut. 2017 May;66(5):966-974. doi: 10.1136/gutjnl-2016-313425. Epub 2017 Feb 23.
5
Treatment of irritable bowel syndrome.
J Clin Pharm Ther. 2011 Jun;36(3):275-82. doi: 10.1111/j.1365-2710.2010.01177.x. Epub 2010 Aug 24.
6
Efficacy and Safety of Peppermint Oil in a Randomized, Double-Blind Trial of Patients With Irritable Bowel Syndrome.
Gastroenterology. 2020 Jan;158(1):123-136. doi: 10.1053/j.gastro.2019.08.026. Epub 2019 Aug 27.
7
Treatment of abdominal pain in irritable bowel syndrome.
J Gastroenterol. 2014 Aug;49(8):1193-205. doi: 10.1007/s00535-014-0966-7. Epub 2014 May 21.
8
Efficacy of soluble fibre, antispasmodic drugs, and gut-brain neuromodulators in irritable bowel syndrome: a systematic review and network meta-analysis.
Lancet Gastroenterol Hepatol. 2020 Feb;5(2):117-131. doi: 10.1016/S2468-1253(19)30324-3. Epub 2019 Dec 16.
9
Bulking agents, antispasmodic and antidepressant medication for the treatment of irritable bowel syndrome.
Cochrane Database Syst Rev. 2005 Apr 18(2):CD003460. doi: 10.1002/14651858.CD003460.pub2.
10
Metabolic and toxicological considerations for the latest drugs used to treat irritable bowel syndrome.
Expert Opin Drug Metab Toxicol. 2013 Apr;9(4):403-21. doi: 10.1517/17425255.2013.759558. Epub 2013 Jan 19.

本文引用的文献

2
Strain-specific and outcome-specific efficacy of probiotics for the treatment of irritable bowel syndrome: A systematic review and meta-analysis.
EClinicalMedicine. 2021 Oct 18;41:101154. doi: 10.1016/j.eclinm.2021.101154. eCollection 2021 Nov.
3
A Rome Working Team Report on Brain-Gut Behavior Therapies for Disorders of Gut-Brain Interaction.
Gastroenterology. 2022 Jan;162(1):300-315. doi: 10.1053/j.gastro.2021.09.015. Epub 2021 Sep 14.
6
Sex-Gender Differences in the Effectiveness of Treatment of Irritable Bowel Syndrome: A Systematic Review.
Int J Gen Med. 2021 Mar 15;14:867-884. doi: 10.2147/IJGM.S291964. eCollection 2021.
7
Diagnosis and Treatment of Irritable Bowel Syndrome: A Review.
JAMA. 2021 Mar 2;325(9):865-877. doi: 10.1001/jama.2020.22532.
8
Efficacy of opioid receptor modulators in patients with irritable bowel syndrome: A systematic review and meta-analysis.
Medicine (Baltimore). 2021 Jan 29;100(4):e24361. doi: 10.1097/MD.0000000000024361.
10
Irritable bowel syndrome.
Lancet. 2020 Nov 21;396(10263):1675-1688. doi: 10.1016/S0140-6736(20)31548-8. Epub 2020 Oct 10.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验